The urinary bladder contains a lining of highly specialized epithelial cells which is known as urothelium or transitional cells. The urothelial cancer develops due to the abnormal growth of urothelium. Urothelial cancer is the most common type of bladder cancer. Urothelial cancer is divided into two types, Invasive and Noninvasive urothelial cancer. In noninvasive urotheliali cancer the inner layers of the urothelial cells are not affected and the tumors can be easily removed. The invasive urothlial cancer affects the inner layer of the bladder which are likely to become metastatic and are hard to treat.
Symptoms of urothelial cancer include blood in urine, pelvic pain, and painful urination. Urothelial cancer is treated through targeted drugs, immunotherapies, chemotherapies and radiation. The tumors are also through various surgical procedures.
Global Urothelial Cancer Treatment Market – Dynamics
Rising incidences of bladder cancer is expected to propel growth of the global urothelial cancer treatment market over the forecast period. For instance, on May 2019, according to the American Society of Clinical Oncology (ASCO), May 2019, urolthelial cancer makes up about 90% of all the bladder cancers.
Moreover, increasing number of new bladder cancer cases is also anticipated to drive the growth of the market during the forecasted period. For instance, according to the World Cancer Research Fund, nearly 550,000 new cases of bladder cancer were reported worldwide in 2018.
Major players are adopting expansion strategies to further strengthen their market position through mergers, agreements and acquisitions which is expected to drive the urothellial cancer treatment market over the forecast period. For instance, in December 2019, Seattle Genetics, Inc. and Astellas Pharma Inc. entered into a collaboration with Merck & Co., Inc., to initiate a phase 3 clinical trial to evaluate enfortumab vedotin and KEYTRUDA for the treatment of metastatic urothelial cancer.
Urothelial Cancer Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients